Long-Term ROSEWOOD Data Confirm Efficacy of Zanubrutinib Plus Obinutuzumab in R/R Follicular Lymphoma onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
While COVID-19 launched cytokine storm syndrome to the forefront of medical research, there is still much to be learned about these hyperactive immune events, according to a presenter at the Biologic Therapies Summit.“A cytokine storm is an immune dysregulation that causes collateral damage,” David Fajgenbaum, MD, MBA, MSc, assistant professor at the Perelman School of Medicine at the